Zacks Investment Research Downgrades Safeguard Scientifics (SFE) to Hold

Safeguard Scientifics (NYSE:SFE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday.

According to Zacks, “Safeguard Scientifics, Inc. is a diversified information technology company that develops, operates and manages emerging growth information technology companies. The company is currently focusing on emerging opportunities in eCommerce, enterprise applications, and network infrastructure, all of which are expected to benefit from the growing use of the Internet as a fundamental business tool. The company works closely with our partnership companies to provide numerous operational and management services to build value in preparation for public rights offerings and beyond. “

A number of other equities research analysts have also recently weighed in on SFE. ValuEngine upgraded shares of Safeguard Scientifics from a “hold” rating to a “buy” rating in a report on Saturday, June 2nd. First Analysis cut shares of Safeguard Scientifics from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $18.00 to $17.00 in a report on Thursday, July 26th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. Safeguard Scientifics has an average rating of “Hold” and an average target price of $18.13.

Shares of SFE opened at $9.00 on Wednesday. The stock has a market capitalization of $192.04 million, a price-to-earnings ratio of -2.07 and a beta of 1.28. The company has a debt-to-equity ratio of 1.60, a quick ratio of 5.03 and a current ratio of 5.03. Safeguard Scientifics has a fifty-two week low of $8.95 and a fifty-two week high of $14.40.

Safeguard Scientifics (NYSE:SFE) last announced its quarterly earnings data on Thursday, July 26th. The asset manager reported ($1.21) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($1.08) by ($0.13). equities analysts predict that Safeguard Scientifics will post -0.79 earnings per share for the current year.

Large investors have recently bought and sold shares of the company. SG Americas Securities LLC purchased a new stake in shares of Safeguard Scientifics during the second quarter valued at approximately $141,000. KBC Group NV grew its holdings in shares of Safeguard Scientifics by 145.9% during the first quarter. KBC Group NV now owns 23,783 shares of the asset manager’s stock valued at $291,000 after buying an additional 14,112 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Safeguard Scientifics by 58.9% during the first quarter. Wells Fargo & Company MN now owns 24,192 shares of the asset manager’s stock valued at $296,000 after buying an additional 8,964 shares during the last quarter. Mycio Wealth Partners LLC purchased a new stake in shares of Safeguard Scientifics during the second quarter valued at approximately $297,000. Finally, FNY Investment Advisers LLC purchased a new stake in shares of Safeguard Scientifics during the second quarter valued at approximately $493,000. Hedge funds and other institutional investors own 72.63% of the company’s stock.

About Safeguard Scientifics

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

Featured Article: Tariff

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply